Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study.
Mukai H, Yamaguchi T, Takahashi M, Hozumi Y, Fujisawa T, Ohsumi S, Akabane H, Nishimura R, Takashima T, Park Y, Sagara Y, Toyama T, Imoto S, Mizuno T, Yamashita S, Fujii S, Uemura Y.
Mukai H, et al. Among authors: yamaguchi t.
Br J Cancer. 2020 Jun;122(12):1747-1753. doi: 10.1038/s41416-020-0815-9. Epub 2020 Apr 2.
Br J Cancer. 2020.
PMID: 32238920
Free PMC article.
Clinical Trial.